Obesity influences the risk of HT, i.e., through activation of the renin–angiotensin–aldosterone (RAS) system, activation of mineralocorticoid receptors, and activation of the sympathetic nervous system (SNS) (24). The gene discussed is NR3C2; the disease is Obesity.